Neil A. Schwarzwalder is a global compendial consultant for the Global Quality Laboratories at Eli Lilly and Company
The Ideal Pharmacopeia
This position paper describes a model for the future that would provide appropriate standardization, facilitate drug registration and support regulatory agencies.